Hadziyannis SJ - Search Results

1

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B.

Alexopoulou A, Owsianka AM, Kafiri G, Dourakis SP, Carman WF, Hadziyannis SJ. Alexopoulou A, et al. Among authors: hadziyannis sj. J Hepatol. 1998 Sep;29(3):345-51. doi: 10.1016/s0168-8278(98)80050-0. J Hepatol. 1998. PMID: 9764979 Clinical Trial.

2

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.

Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, Hadziyannis S. Deutsch M, et al. Hepatology. 1997 Jul;26(1):206-10. doi: 10.1002/hep.510260127. Hepatology. 1997. PMID: 9214471

3

Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: a randomized study.

Hadziyannis S, Alexopoulou A, Papakonstantinou A, Petraki K, Manesis E. Hadziyannis S, et al. J Viral Hepat. 2000 May;7(3):235-40. doi: 10.1046/j.1365-2893.2000.00220.x. J Viral Hepat. 2000. PMID: 10849267 Clinical Trial.

4

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients.

Manesis EK, Papaioannou C, Gioustozi A, Kafiri G, Koskinas J, Hadziyannis SJ. Manesis EK, et al. Among authors: hadziyannis sj. Hepatology. 1997 Sep;26(3):734-9. doi: 10.1002/hep.510260327. Hepatology. 1997. PMID: 9303505 Clinical Trial.

5

Splenic infarct as a late complication of liver transplantation.

Dourakis SP, Alexopoulou AA, Hadziyannis SJ. Dourakis SP, et al. Among authors: hadziyannis sj. Eur J Gastroenterol Hepatol. 1998 Sep;10(9):805-8. doi: 10.1097/00042737-199809000-00015. Eur J Gastroenterol Hepatol. 1998. PMID: 9831279

6

Gliclazide-induced acute hepatitis.

Dourakis SP, Tzemanakis E, Sinani C, Kafiri G, Hadziyannis SJ. Dourakis SP, et al. Among authors: hadziyannis sj. Eur J Gastroenterol Hepatol. 2000 Jan;12(1):119-21. doi: 10.1097/00042737-200012010-00021. Eur J Gastroenterol Hepatol. 2000. PMID: 10656221

7

Fulminant hepatitis after flutamide treatment.

Dourakis SP, Alexopoulou AA, Hadziyannis SJ. Dourakis SP, et al. Among authors: hadziyannis sj. J Hepatol. 1994 Mar;20(3):350-3. doi: 10.1016/s0168-8278(94)80006-5. J Hepatol. 1994. PMID: 8014445

8

Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection.

Hadziyannis SJ, Hadziyannis AS, Dourakis S, Alexopoulou A, Horsch A, Hess G. Hadziyannis SJ, et al. Among authors: hadziyannis as. Hepatogastroenterology. 1993 Dec;40(6):588-92. Hepatogastroenterology. 1993. PMID: 8119645

9

Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma.

Hadziyannis SJ, Giannoulis G, Hadziyannis E, Kaklamani E, Alexopoulou A, Dourakis S, Trichopoulos D. Hadziyannis SJ, et al. Among authors: hadziyannis e. J Hepatol. 1993;17 Suppl 3:S72-7. doi: 10.1016/s0168-8278(05)80428-3. J Hepatol. 1993. PMID: 8389786

10

Immune thrombocytopenia and alpha-interferon therapy.

Dourakis SP, Deutsch M, Hadziyannis SJ. Dourakis SP, et al. Among authors: hadziyannis sj. J Hepatol. 1996 Dec;25(6):972-5. doi: 10.1016/s0168-8278(96)80304-7. J Hepatol. 1996. PMID: 9007728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page